About this episode
It looks like the market is having a tide change with regards to how it handle's Covid. We have avoided analyzing covid too much, at least much less than the founding of this channel (in anticipation of a covid downturn, just prior to the covid sell of beginning). However, it appears the market is beginning to have a tide change towards rationality, or at least an increase in pharmaceuticals available to treat covid. Today we're seeing vaccine stocks up big. We're also seeing oil stocks up and rates rising comfortably, with covid beneficiaries down. This wholistic picture shows me, and maybe us, that the market is now assigning a high value to covid treatments and vaccines. It may be unlikely that reopening beneficiaries get an emotional hit because of covid, and that covid beneficiaries get a boost because cases are rising. We're seeing the opposite today in the ladder. They may now be judged based on their underlying performance regardless of Covid, like Zoom beating earnings today. We'll see what happens.
Comments
Rate this episode
Episode Details
- Author
- Billy LoBue
- Show Type
- full
- Audio Format
- audio/x-m4a
